FDA gadolinium alert

The FDA along with the ACR has stayed on top of the Gadolinium concerns of many, in the last year. This latest update is now asking all of the Gadolinium pharmaceutical companies to change the packaging to warn about NSF. The FDA has provided some information for Healthcare Providers to better understand and to handle the complexities of this patient population. They have also set-up some FAQ for people.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s